Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.805 USD | -3.28% | -32.00% | -42.73% |
02:12pm | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
05-14 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.73% | 143M | |
+13.02% | 227B | |
+13.48% | 192B | |
+18.09% | 136B | |
+28.33% | 108B | |
+1.67% | 64.07B | |
+17.59% | 52.1B | |
+7.04% | 51.87B | |
+10.85% | 44.33B | |
+6.26% | 36.75B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Morgan Stanley Trims Akoya Biosciences Price Target to $18 From $19, Maintains Overweight Rating